← Back to Clinical Trials
Recruiting NCT05318222

Genetic Inclusion by Virtual Evaluation

Trial Parameters

Condition Birth Defects
Sponsor Baylor College of Medicine
Study Type INTERVENTIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 1 Day
Max Age 18 Years
Start Date 2022-06-01
Completion 2027-01-31
Interventions
Whole genome sequencing (WGS)

Brief Summary

This study aims to transform the current clinical practice paradigm by leveraging an internally designed web-based model of delivery of care called Consultagene to provide remote evaluation and genomic sequencing for improving genetic health of less resourced children with rare disorders living along the Texas-Mexico border.

Eligibility Criteria

Inclusion Criteria: Pediatric patients with undiagnosed rare genetic diseases residing in the Rio Grande Valley and El Paso in Texas Exclusion Criteria: Children with known genetic diseases

Related Trials